Antipsychotic-induced movement disorders: evaluation and treatment.
作者信息
Mathews Maju, Gratz Sylvia, Adetunji Babatunde, George Vinu, Mathews Manu, Basil Biju
机构信息
Dr. Maju Mathews is Assistant Professor of Psychiatry, Drexel University College of Medicine, Philadelphia, Pennsylvania.
出版信息
Psychiatry (Edgmont). 2005 Mar;2(3):36-41.
Abstract
摘要
相似文献
1
Antipsychotic-induced movement disorders: evaluation and treatment.抗精神病药物所致运动障碍：评估与治疗
Psychiatry (Edgmont). 2005 Mar;2(3):36-41.
2
Antipsychotic-Induced movement disorders in the elderly: epidemiology and treatment recommendations.老年人抗精神病药物所致运动障碍：流行病学及治疗建议
Drugs Aging. 2000 Nov;17(5):363-84. doi: 10.2165/00002512-200017050-00004.
3
Prevalence and pattern of antipsychotic induced movement disorders in a tertiary care teaching hospital in India - a cross-sectional study.抗精神病药引起的运动障碍在印度一家三级教学医院的流行情况和模式：一项横断面研究。
Int J Psychiatry Clin Pract. 2018 Jun;22(2):101-108. doi: 10.1080/13651501.2017.1381268. Epub 2017 Sep 27.
4
Pathophysiology of antipsychotic drug-induced movement disorders.抗精神病药物所致运动障碍的病理生理学
J Clin Psychiatry. 2004;65 Suppl 9:25-8.
5
Antipsychotic medications and drug-induced movement disorders other than parkinsonism: a population-based cohort study in older adults.抗精神病药物与除帕金森症外的药物性运动障碍：一项针对老年人的基于人群的队列研究
J Am Geriatr Soc. 2005 Aug;53(8):1374-9. doi: 10.1111/j.1532-5415.2005.53418.x.
6
Antipsychotic-Induced Movement Disorder: Screening via Telemental Health.抗精神病药物所致运动障碍：通过远程心理健康进行筛查
Telemed J E Health. 2015 Dec;21(12):1027-9. doi: 10.1089/tmj.2014.0242. Epub 2015 Jun 30.
7
Implications of Antipsychotic Use: Antipsychotic-Induced Movement Disorders, with a Focus on Tardive Dyskinesia.抗精神病药使用的影响：抗精神病药引起的运动障碍，重点是迟发性运动障碍。
Nurs Clin North Am. 2019 Dec;54(4):595-608. doi: 10.1016/j.cnur.2019.08.004. Epub 2019 Oct 10.
8
Pharmacogenetics of antipsychotic-induced movement disorders as a resource for better understanding Parkinson's disease modifier genes.抗精神病药物所致运动障碍的药物遗传学：作为更好理解帕金森病修饰基因的资源
Front Neurol. 2015 Feb 20;6:27. doi: 10.3389/fneur.2015.00027. eCollection 2015.
9
Prevalence of neuroleptic-induced movement disorders: an 8-year follow-up study in chronic schizophrenia inpatients.抗精神病药物所致运动障碍的患病率：对慢性精神分裂症住院患者的8年随访研究
Nord J Psychiatry. 2016 Oct;70(7):498-502. doi: 10.3109/08039488.2016.1164245. Epub 2016 Apr 19.
10
Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.“非典型”抗精神病药物阿立哌唑所致的运动障碍
Neurologist. 2017 Jan;22(1):24-28. doi: 10.1097/NRL.0000000000000096.
引用本文的文献
1
Voice-Based Assessment of Extrapyramidal Symptoms Using Deep Learning.基于深度学习的锥体外系症状语音评估
Sensors (Basel). 2025 Aug 11;25(16):4968. doi: 10.3390/s25164968.
2
The evidence and impact of deprescribing on sarcopenia parameters: a systematic review.减药对肌肉减少症参数的证据及影响：一项系统综述
BMC Geriatr. 2025 Mar 7;25(1):158. doi: 10.1186/s12877-025-05819-7.
3
Liquid antipsychotics in the management of psychomotor agitation: a focus on promazine.液态抗精神病药物在治疗精神运动性激越中的应用：聚焦于丙嗪
Drugs Context. 2024 Nov 21;13. doi: 10.7573/dic.2024-6-5. eCollection 2024.
4
The Association Between Psychotropic Medication Use and Gait and Mobility Impairment in Community-Dwelling Older People: Data From The Irish Longitudinal Study on Ageing (TILDA).社区居住老年人使用精神药物与步态及行动能力障碍之间的关联：来自爱尔兰老龄化纵向研究（TILDA）的数据。
J Gerontol A Biol Sci Med Sci. 2025 Apr 7;80(5). doi: 10.1093/gerona/glae263.
5
Case report: IORT as an alternative treatment option for breast cancer patients with difficulty staying still.病例报告：术中放疗作为难以保持静止的乳腺癌患者的一种替代治疗选择。
Front Oncol. 2024 Sep 24;14:1429326. doi: 10.3389/fonc.2024.1429326. eCollection 2024.
6
Exercise and Schizophrenia.锻炼与精神分裂症。
Curr Top Behav Neurosci. 2024;67:367-379. doi: 10.1007/7854_2024_505.
7
Exploring the Relationships Between Antipsychotic Dosage and Voice Characteristics in Relation to Extrapyramidal Symptoms.探究抗精神病药物剂量与语音特征之间与锥体外系症状相关的关系。
Psychiatry Investig. 2024 Aug;21(8):822-831. doi: 10.30773/pi.2023.0417. Epub 2024 Aug 8.
8
The Impact of High-density Lipoprotein Cholesterol (HDL-C) Levels and Risk of Movement Disorders in Patients Taking Antipsychotics.服用抗精神病药物患者的高密度脂蛋白胆固醇（HDL-C）水平与运动障碍风险的影响
Innov Clin Neurosci. 2024 Jun 1;21(4-6):27-30. eCollection 2024 Apr-Jun.
9
Acute Extrapyramidal Side Effects Associated With the Combined Use of Low Doses of Haloperidol and Clarithromycin.低剂量氟哌啶醇与克拉霉素联合使用相关的急性锥体外系副作用
Cureus. 2023 Dec 24;15(12):e51020. doi: 10.7759/cureus.51020. eCollection 2023 Dec.
10
Differentiating Between Lithium Tremors and Extrapyramidal Tremors in a Patient on Long-Term Antipsychotics and Lithium Medication.长期服用抗精神病药物和锂盐的患者中锂盐震颤与锥体外系震颤的鉴别
Cureus. 2023 Jul 24;15(7):e42406. doi: 10.7759/cureus.42406. eCollection 2023 Jul.
本文引用的文献
1
Physical health monitoring of patients with schizophrenia.精神分裂症患者的身体健康监测。
Am J Psychiatry. 2004 Aug;161(8):1334-49. doi: 10.1176/appi.ajp.161.8.1334.
2
Naltrexone treatment of tardive dyskinesia in patients with schizophrenia.
J Clin Psychopharmacol. 2004 Aug;24(4):441-5. doi: 10.1097/01.jcp.0000132440.27854.44.
3
Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men.支链氨基酸对男性迟发性运动障碍的治疗效果。
Am J Psychiatry. 2003 Jun;160(6):1117-24. doi: 10.1176/appi.ajp.160.6.1117.
4
Deep brain stimulation in dystonia.肌张力障碍的深部脑刺激疗法
J Neurol. 2003 Feb;250 Suppl 1:I47-52. doi: 10.1007/s00415-003-1110-2.
5
Atypical antipsychotics in the EPS-vulnerable patient.
Psychoneuroendocrinology. 2003 Jan;28 Suppl 1:39-51. doi: 10.1016/s0306-4530(02)00111-7.
6
Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.喹硫平改善三名精神分裂症患者的迟发性运动障碍。
Int Clin Psychopharmacol. 2002 Sep;17(5):263-4. doi: 10.1097/00004850-200209000-00006.
7
Immediate effect of intravenous diazepam in neuroleptic-induced acute akathisia: an open-label study.
J Clin Psychiatry. 2002 Jun;63(6):524-7. doi: 10.4088/jcp.v63n0610.
8
Treatment of tardive dyskinesia with donepezil: a pilot study.多奈哌齐治疗迟发性运动障碍：一项试点研究。
J Clin Psychiatry. 2001 Oct;62(10):772-5. doi: 10.4088/jcp.v62n1004.
9
Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study.褪黑素治疗迟发性运动障碍：一项双盲、安慰剂对照、交叉研究。
Arch Gen Psychiatry. 2001 Nov;58(11):1049-52. doi: 10.1001/archpsyc.58.11.1049.
10
Vitamin E for neuroleptic-induced tardive dyskinesia.维生素E用于治疗抗精神病药所致迟发性运动障碍。
Cochrane Database Syst Rev. 2001(4):CD000209. doi: 10.1002/14651858.CD000209.
Zotero 插件